US 11174246
Direct AMPK activators
granted A61PA61P3/10A61P43/00
Quick answer
US patent 11174246 (Direct AMPK activators) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61P, A61P3/10, A61P43/00, A61P9/00, A61P9/10